Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 13.16
- Piotroski Score 6.00
- Grade Buy
- Symbol (SRTS)
- Company Sensus Healthcare, Inc.
- Price $5.79
- Changes Percentage (-1.53%)
- Change -$0.09
- Day Low $5.70
- Day High $5.91
- Year High $7.18
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/07/2024
- Fiscal Year End N/A
- Average Stock Price Target $10.00
- High Stock Price Target $10.00
- Low Stock Price Target $10.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.29
- Trailing P/E Ratio 19
- Forward P/E Ratio 19
- P/E Growth 19
- Net Income $485,000
Income Statement
Quarterly
Annual
Latest News of SRTS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Optimism for Sensus Healthcare (NASDAQ:SRTS) has grown this past week, despite one-year decline in earnings
Passive investing in index funds yields market-matching returns, but picking individual stocks can outperform. Sensus Healthcare stock surged 100% in a year, outperforming the market, despite a 16% fa...
By Yahoo! Finance | 2 months ago -
We Like These Underlying Return On Capital Trends At Sensus Healthcare (NASDAQ:SRTS)
To identify a multi-bagger stock, focus on increasing Return on Capital Employed (ROCE) and expanding capital employed. Sensus Healthcare (NASDAQ:SRTS) shows a positive trend in ROCE, generating 11% r...
By Yahoo! Finance | 3 months ago
